Kewaunee Scientific Corporation (KEQU)
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Investigation
05/14/2021
Initial Lawsuit
05/14/2021
Lawsuit Progression
09/21/2021
Investigation regarding the negative impact of rising steel and freight costs on Array’s operations and relevant public offerings.
05/11/2021
Array Technologies publishes its Q1 2021 financial results press release, showing steel and freight cost impact on its margins and announcing potential impact in subsequent quarters because of the company’s previous decision to “let [its] suppliers take [the hedging] risk on“:
“We are taking several actions to mitigate the impact on the balance of the year, including passing through higher commodity and shipping costs to our customers, fixing commodity prices with our suppliers, entering into long-term contracts with freight providers, further diversifying our supply base, and increasing order lead-times to give us more time to procure raw material.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$13.46 | $24.95 | $-11.49 | -46.05% |
Plaintiff brings this securities class action on behalf of:
(a) All persons or entities who purchased or otherwise acquired Array securities between October 14, 2020, and May 11, 2021, inclusive; and
(b) All persons and entities that purchased or otherwise acquired Array common stock pursuant, or traceable, or both, to: (i) the registration statement and prospectus issued in connection with the Company’s October 2020 initial public offering; or (ii) the registration statement and prospectus issued in connection with the Company’s December 2020 offering; or (iii) the registration statement and prospectus issued in connection with the Company’s March 2021 offering; or (iv) any combination of the IPO, December 2020 SPO, or March 2021 SPO.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) [Defendants were having] issues revolving around, inter alia, material negative impacts of rising steel and freight costs on its operations
(ii) Defendants repeatedly and consistently painted a materially misleading picture of the Company’s business and prospects that did not reflect these rising costs.
09/21/2021
The court issued an order appointing the lead plaintiff and lead counsel.
12/07/2021
This securities class action is brought on behalf of: (a) All persons and entities that purchased or otherwise acquired Array securities during the period from October 14, 2020, through May 11, 2021, inclusive . . .; and (b) All persons and entities that purchased or otherwise acquired Array common stock pursuant, or traceable, or both, to: (i) the registration statement and prospectus issued in connection with the company’s October 2020 initial public offering (IPO); or (ii) the registration statement and prospectus issued in connection with the company’s December 2020 secondary offering (SPO); or (iii) the registration statement and prospectus issued in connection with the company’s March 2021 secondary offering (SPO); or (iv) any combination of the IPO, December 2020 SPO, or March 2021 SPO . . .
Operative complaint
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.